Skip to main content
OpenTrials
Completed

NCT Number: NCT05259293

Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care

The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or within a few hours (delayed pneumothorax). The incidence of pneumothorax in the literature is very different from one study to another: it has been reported to be from 9 to 54% in patients undergoing percutaneous transthoracic needle biopsy. This difference of incidence could be explained by the absence of consensus for the definition of an iatrogenic pneumothorax.

The characteristics of pneumothorax and the management of patients with iatrogenic pneumothorax will be evaluated in different centres in a retrospective manner. This study will contribute to refining the criteria for defining pneumothorax occurring during lung biopsy and will provide a better understanding of the condition and its management.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pneumothorax Iatrogenic Postprocedural

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Besançon, Besançon, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years old and more at the time of the biopsy procedure in year 2020
  • Having had a pneumothorax following their transthoracic percutaneous lung biopsy in year 2020

Exclusion criteria

  • Objection to the use of the data (French sites only)

Treatment and study plan

No intervention - retrospective study

Other

This is a retrospective study. No intervention.

Primary outcomes

  1. Annual incidence rate of pneumothorax related to transthoracic lung biopsy on total number of lung biopsies

    Time frame: 3 months

Secondary outcomes

  1. Annual incidence rate of hospitalisation in patients with pneumothorax related to lung biopsies

    Time frame: 3 months

  2. Annual incidence rate of drainage in patients with pneumothorax related to lung biopsies

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

Registry information

Official study title

Characteristics of Pneumothorax Associated With Transthoracic Percutaneous Lung Biopsy in Standard of Care: a Retrospective Study in 6 Centers

Acronym: PNOrate

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 28, 2022
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.